Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease. 2022

Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY (A.D.-R., R.A.G., K.S., M.G.-F., T.R.S., A.N.-A.).

Epigenetic dysregulation has been proposed as a key mechanism for arsenic-related cardiovascular disease (CVD). We evaluated differentially methylated positions (DMPs) as potential mediators on the association between arsenic and CVD. Blood DNA methylation was measured in 2321 participants (mean age 56.2, 58.6% women) of the Strong Heart Study, a prospective cohort of American Indians. Urinary arsenic species were measured using high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry. We identified DMPs that are potential mediators between arsenic and CVD. In a cross-species analysis, we compared those DMPs with differential liver DNA methylation following early-life arsenic exposure in the apoE knockout (apoE-/-) mouse model of atherosclerosis. A total of 20 and 13 DMPs were potential mediators for CVD incidence and mortality, respectively, several of them annotated to genes related to diabetes. Eleven of these DMPs were similarly associated with incident CVD in 3 diverse prospective cohorts (Framingham Heart Study, Women's Health Initiative, and Multi-Ethnic Study of Atherosclerosis). In the mouse model, differentially methylated regions in 20 of those genes and DMPs in 10 genes were associated with arsenic. Differential DNA methylation might be part of the biological link between arsenic and CVD. The gene functions suggest that diabetes might represent a relevant mechanism for arsenic-related cardiovascular risk in populations with a high burden of diabetes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D001151 Arsenic A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed) Arsenic-75,Arsenic 75
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses

Related Publications

Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
September 2012, Epidemiology (Cambridge, Mass.),
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
July 2012, Environmental health perspectives,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
July 2013, Environmental health perspectives,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
May 2014, Epigenetics,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
January 2021, Cardiology in review,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
January 2012, PloS one,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
July 2020, Current opinion in clinical nutrition and metabolic care,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
February 2010, Epigenomics,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
October 2019, Clinical epigenetics,
Arce Domingo-Relloso, and Kiran Makhani, and Angela L Riffo-Campos, and Maria Tellez-Plaza, and Kathleen Oros Klein, and Pooja Subedi, and Jinying Zhao, and Katherine A Moon, and Anne K Bozack, and Karin Haack, and Walter Goessler, and Jason G Umans, and Lyle G Best, and Ying Zhang, and Miguel Herreros-Martinez, and Ronald A Glabonjat, and Kathrin Schilling, and Marta Galvez-Fernandez, and Jack W Kent, and Tiffany R Sanchez, and Kent D Taylor, and W Craig Johnson, and Peter Durda, and Russell P Tracy, and Jerome I Rotter, and Stephen S Rich, and David Van Den Berg, and Silva Kasela, and Tuuli Lappalainen, and Ramachandran S Vasan, and Roby Joehanes, and Barbara V Howard, and Daniel Levy, and Kurt Lohman, and Yongmei Liu, and M Daniele Fallin, and Shelley A Cole, and Koren K Mann, and Ana Navas-Acien
January 2014, Molecular nutrition & food research,
Copied contents to your clipboard!